• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | Registration & Listing | Adverse Events | Recalls | PMA | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Recognition List Number: 024 Publication Date: 06/10/2010 

Part B: SUPPLEMENTARY INFORMATION

Recognition Number 12-211: IEC 60601-2-29 Edition 3.0 2008-06, Medical electrical equipment - Part 2-29: Particular requirements for the basic safety and essential performance of radiotherapy simulators. (Radiology)

Date of Standard: 2008. 
Address of Standards Organization:
  International Electrotechnical Commission (IEC)
  3, Rue de Varembe'
  PO Box 131
  CH-1211 Geneva 20, 0
  SWITZERLAND
CDRH Office and Division Associated with Recognized Standards:
OFFICE OF IN VITRO DIAGNOSTICS AND RADIOLOGICAL HEALTH (OIR)
Devices Affected:
Radiation Therapy Simulation Systems
Processes Affected:
510(k), PMA, PDP, IDE, HDE
Type of Standard:
 Vertical, International
Extent of Recognition:
Complete Standard and any annexes with specific national alterations for areas not covered by 21 CFR Subchapter J (1000, et. al.).

Transition:
FDA recognition of Second Edition IEC 60601-2-29:1999 is hereby superseded by recognition of IEC 60601-2-29 Edition 3.0 2008-06 Medical electrical equipment - Part 2-29: Particular requirements for the basic safety and essential performance of radiotherapy simulators. FDA will accept declaration of conformity, in support of premarket submissions, to Second Edition IEC 60601-2-29 until June 30, 2013. After this transitional period, declaration of conformity to Second Edition: 1999 of the standard will not be accepted.
Related CFR Citations and Product Codes:
Regulation
Number
Device Name Device
Class
Product
Code
§892.5840 System, Simulation, Radiation Therapy Class 2 KPQ
 
Relevant Guidance:
There is no relevant guidance developed at this time.
FDA Technical Contact:
  John Chen
  FDA/CDRH/OIVD
  10903 New Hampshire Avenue Building 66, Room G302
  Silver Spring MD 20993
  301/796-6540
  Email: john.chen@fda.hhs.gov
* In the United States, copies of this standard can be obtained from:
  American National Standards Institute (ANSI)*
  25 West 43rd Street
  4th Floor
  New York, NY 10036
-
-